華虹半導體(01347.HK)向子公司華虹無錫101名僱員授出248.2萬份股票期權
格隆匯12月23日丨華虹半導體(01347.HK)公佈,於2019年12月23日,公司根據於2015年9月1日採納的現有股票期權計劃向華虹半導體(無錫)有限公司具有重要技術專長及擔任核心管理職位的101名僱員授出248.2萬份股票期權,可認購合共最多350萬股該公司普通股,期權的行權價17.952港元,公司近5日平均收市價17.952港元。
華虹無錫目前為公司非全資子公司,主要從事12英寸(300mm)晶圓集成電路的設計、研究、製造、測試、封裝及銷售。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.